Verala Med: what changed
Verala Med
Largest movements
- Current investments +€221,643
up €221,643 (+81.9%), from €270,511 to €492,154
- Cash +€19,683
up €19,683 (+83.3%), from €23,627 to €43,310
mainly Net result for the year (+€220,501) and Tax, wage and social debts (+€34,900)
- Receivables within one year +€12,222
up €12,222 (+2,315%), from €528 to €12,750
- Reserves +€220,501
up €220,501 (+96.7%), from €227,909 to €448,410
- Tax, wage and social debts +€34,900
up €34,900 (+54.5%), from €64,016 to €98,916
of which Taxes: +€32,271
- Gross operating margin +€70,839
up €70,839 (+28.5%), from €248,699 to €319,538
- Taxes +€22,905
up €22,905 (+28.9%), from €79,227 to €102,133
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €294,666 | €550,647 | +€255,981 | +86.9% |
| Fixed assets | 21/28 | - | €2,433 | +€2,433 | |
| Tangible fixed assets | 22/27 | - | €2,433 | +€2,433 | |
| Furniture and vehicles | 24 | - | €2,433 | +€2,433 | |
| Current assets | 29/58 | €294,666 | €548,214 | +€253,548 | +86.0% |
| Amounts receivable within one year | 40/41 | €528 | €12,750 | +€12,222 | +2,315% |
| Trade receivables | 40 | €528 | €12,750 | +€12,222 | +2,315% |
| Current investments | 50/53 | €270,511 | €492,154 | +€221,643 | +81.9% |
| Cash at bank and in hand | 54/58 | €23,627 | €43,310 | +€19,683 | +83.3% |
| Total equity and liabilities | 10/49 | €294,666 | €550,647 | +€255,981 | +86.9% |
| Equity | 10/15 | €230,409 | €450,910 | +€220,501 | +95.7% |
| Contributions | 10/11 | €2,500 | €2,500 | = | 0.0% |
| Reserves | 13 | €227,909 | €448,410 | +€220,501 | +96.7% |
| Distributable reserves | 133 | €227,909 | €448,410 | +€220,501 | +96.7% |
| Amounts payable | 17/49 | €64,256 | €99,736 | +€35,480 | +55.2% |
| Amounts payable within one year | 42/48 | €64,017 | €99,416 | +€35,399 | +55.3% |
| Trade debts | 44 | €1 | €500 | +€499 | +50,440% |
| Suppliers | 440/4 | €1 | €500 | +€499 | +50,440% |
| Taxes, remuneration and social security | 45 | €64,016 | €98,916 | +€34,900 | +54.5% |
| Taxes | 450/3 | €60,809 | €93,080 | +€32,271 | +53.1% |
| Remuneration and social security | 454/9 | €3,207 | €5,836 | +€2,628 | +81.9% |
| Accrued charges and deferred income | 492/3 | €239 | €320 | +€81 | +33.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €146 | +€146 | |
| Other operating charges | 640/8 | - | €144 | +€144 | |
| Gross operating margin | 9900 | €248,699 | €319,538 | +€70,839 | +28.5% |
| Operating profit (loss) | 9901 | €248,699 | €319,248 | +€70,548 | +28.4% |
| Financial income | 75/76B | €730 | €3,776 | +€3,045 | +417% |
| Recurring financial income | 75 | €730 | €3,776 | +€3,045 | +417% |
| Financial charges | 65/66B | €279 | €390 | +€111 | +39.7% |
| Recurring financial charges | 65 | €279 | €390 | +€111 | +39.7% |
| Profit (loss) for the period before taxes | 9903 | €249,151 | €322,634 | +€73,483 | +29.5% |
| Income taxes | 67/77 | €79,227 | €102,133 | +€22,905 | +28.9% |
| Profit (loss) for the period | 9904 | €169,923 | €220,501 | +€50,578 | +29.8% |
| Profit (loss) for the period to be appropriated | 9905 | €169,923 | €220,501 | +€50,578 | +29.8% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 6 November 2026 via checked.be.